Home Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy
Article
Licensed
Unlicensed Requires Authentication

Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy

  • Shruti Sastry , Christine A. March EMAIL logo , Michael J. McPhaul and Luigi R. Garibaldi
Published/Copyright: November 23, 2023

Abstract

Objectives

Although AVP and its surrogate, copeptin, are mainly regulated by osmotic and volume stimuli, their secretion is also elicited by stress and growth hormone (GH) stimulating agents. The aim of this report is to describe unusual patterns of copeptin response in a subset of children undergoing GH stimulation tests (GH-ST).

Methods

We conducted a secondary analysis of a cohort of 93 healthy short children with no polydipsia, polyuria or fluid/electrolyte abnormalities, undergoing GH-ST with intravenous arginine, insulin, oral clonidine, or L-Dopa/carbidopa in various combinations. Serum copeptin concentrations were measured 1–3 min after phlebotomy (0 min) and at 60, 90, 120 min during GH-ST.

Results

In 85 subjects (normal response group, NRG) serum copeptin concentrations increased from a 0 min median of 9 pmol/L (IQR 6, 11.5) (all values ≤21) to a median peak between 60 and 120 min of 22 (IQR15, 38) pmol/L, which varied depending on the stimulating agent. Conversely, in the eight outliers, copeptin concentrations decreased gradually from a median of 154 (IQR 61, 439) pmol/L (all ≥40 pmol/L) to values as low as 14 % of the basal value, by 120 min. Test-associated anxiety was described in 17 subjects in the NRG (20 %) and five of the outliers (63 %).

Conclusions

A distinctive pattern of very elevated serum copeptin concentrations occurred in 9 % of children undergoing GH-ST, similar to reports in previous pediatric studies. Etiology may include pain or stress of phlebotomy. This phenomenon should be recognized for proper interpretation of copeptin values in children.


Corresponding author: Christine A. March, MD, MS, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; and Division of Pediatric Endocrinology, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, E-mail:

Acknowledgments

We wish to thank our study participants and all the personnel at both the Children’s Hospital of Pittsburgh and Quest Diagnostics for assisting with specimen handling and laboratory Assays.

  1. Research ethics: This study protocol was reviewed and approved by the University of Pittsburgh Institutional Review Board, approval number 19120068. The study was conducted in accordance with the Declaration of Helsinki.

  2. Informed consent: Written informed consent was obtained from the participants’ parent/legal guardian/next of kin to participate in the study.

  3. Author contributions: Dr. Luigi Garibaldi conceptualized the study. Study activities were completed by Dr. Luigi Garibaldi and Dr. Shruti Sastry, laboratory measurements supervised by Dr. Michael J McPhaul, and analysis by Dr. Christine March. Dr. Luigi Garibaldi drafted the initial manuscript, which was edited by all authors. All authors reviewed and approved the final version of the manuscript.

  4. Competing interests: Dr. Michael J. McPhaul is a consultant for Quest Diagnostics and owns stock in the company. The other authors have no significant conflicts to disclose.

  5. Research funding: Dr. Christine A. March is funded by the University of Pittsburgh Clinical and Translational Science Institute Clinical and Translational Science Scholars Program (NIH/NCATS 1 KL2 TR001856, PI: Rubio).

  6. Data availability: All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.

References

1. Szczepanska-Sadowska, E, Zera, T, Sosnowski, P, Cudnoch-Jedrzejewska, A, Puszko, A, Misicka, A. Vasopressin and related peptides; potential value in diagnosis, prognosis and treatment of clinical disorders. Curr Drug Metab 2017;18:306–45. https://doi.org/10.2174/1389200218666170119145900.Search in Google Scholar PubMed

2. Kloter, M, Gregoriano, C, Haag, E, Kutz, A, Mueller, B, Schuetz, P. Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study. Endocr Connect 2021;10:995–1005. https://doi.org/10.1530/ec-21-0211.Search in Google Scholar PubMed PubMed Central

3. Jochberger, S, Morgenthaler, NG, Mayr, VD, Luckner, G, Wenzel, V, Ulmer, H, et al.. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 2006;91:4381–6. https://doi.org/10.1210/jc.2005-2830.Search in Google Scholar PubMed

4. Ahmed, TAN, Johny, JS, Abdel-Malek, MY, Fouad, DA. The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes. Am J Emerg Med 2021;50:413–21. https://doi.org/10.1016/j.ajem.2021.08.069.Search in Google Scholar PubMed

5. Bonnet, L, Marquant, E, Fromonot, J, Hamouda, I, Berbis, J, Godefroy, A, et al.. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children. Clin Endocrinol 2022;96:47–53. https://doi.org/10.1111/cen.14620.Search in Google Scholar PubMed

6. Binder, G, Weber, K, Peter, A, Schweizer, R. Arginine-stimulated copeptin in children and adolescents. Clin Endocrinol 2023;98:548–53. https://doi.org/10.1111/cen.14880.Search in Google Scholar PubMed

7. March, CA, Sastry, S, McPhaul, MJ, Wheeler, SE, Garibaldi, L. Combined arginine and insulin stimulation elicits a robust and consistent copeptin response in short children. Horm Res Paediatr 2023;96:395–403. https://doi.org/10.1159/000528661.Search in Google Scholar PubMed PubMed Central

8. Winzeler, B, Cesana-Nigro, N, Refardt, J, Vogt, DR, Imber, C, Morin, B, et al.. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet 2019;394:587–95. https://doi.org/10.1016/s0140-6736(19)31255-3.Search in Google Scholar PubMed

9. Rothballer, AB. Changes in the rat neurohypophysis induced by painful stimuli with particular reference to neurosecretory material. Anatomical Rec 1953;115:21–41. https://doi.org/10.1002/ar.1091150103.Search in Google Scholar PubMed

10. Morgenthaler, NG, Struck, J, Jochberger, S, Dunser, MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008;19:43–9. https://doi.org/10.1016/j.tem.2007.11.001.Search in Google Scholar PubMed

11. Mirsky, IA, Paulisch, G, Stein, M, Jinks, R. The antidiuretic activity of the plasma of adrenalectomized, hypophysectomized and adrenalectomized-hypophysectomized rats. Endocrinology 1954;54:691–7. https://doi.org/10.1210/endo-54-6-691.Search in Google Scholar PubMed

12. Ueta, Y, Dayanithi, G, Fujihara, H. Hypothalamic vasopressin response to stress and various physiological stimuli: visualization in transgenic animal models. Horm Behav 2011;59:221–6. https://doi.org/10.1016/j.yhbeh.2010.12.007.Search in Google Scholar PubMed

13. Kendler, KS, Weitzman, RE, Fisher, DA. The effect of pain on plasma arginine vasopressin concentrations in man. Clin Endocrinol 1978;8:89–94. https://doi.org/10.1111/j.1365-2265.1978.tb02156.x.Search in Google Scholar PubMed

14. Haas, M, Glick, SM. Radioimmunoassayable plasma vasopressin associated with surgery. Arch Surg 1978;113:597–600. https://doi.org/10.1001/archsurg.1978.01370170059011.Search in Google Scholar PubMed

15. Deveci, OS, Ozmen, C, Karaaslan, MB, Celik, AI, Rahimova, H, Akray, A, et al.. Increased circulating copeptin levels are associated with vaso-occlusive crisis and right ventricular dysfunction in sickle cell anemia. Med Princ Pract 2022;31:47–53. https://doi.org/10.1159/000521216.Search in Google Scholar PubMed PubMed Central

16. Christ-Crain, M, Refardt, J, Winzeler, B. Approach to the patient: “utility of the copeptin assay”. J Clin Endocrinol Metab 2022;107:1727–38. https://doi.org/10.1210/clinem/dgac070.Search in Google Scholar PubMed PubMed Central

17. Chortis, V, Bancos, I, Crowley, RK, Arlt, W. Supine or sitting plasma metanephrine screening? A unifying solution for patients and doctors. Clin Endocrinol 2015;82:776–7. https://doi.org/10.1111/cen.12659.Search in Google Scholar PubMed

18. Darr, R, Pamporaki, C, Peitzsch, M, Miehle, K, Prejbisz, A, Peczkowska, M, et al.. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions. Clin Endocrinol 2014;80:478–86. https://doi.org/10.1111/cen.12327.Search in Google Scholar PubMed

19. Eisenhofer, G, Deutschbein, T, Constantinescu, G, Langton, K, Pamporaki, C, Calsina, B, et al.. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. Clin Chem Lab Med 2020;59:353–63. https://doi.org/10.1515/cclm-2020-0904.Search in Google Scholar PubMed

20. Eijkelenkamp, K, van Geel, EH, Kerstens, MN, van Faassen, M, Kema, IP, Links, TP, et al.. Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects. Clin Chem Lab Med 2020;58:1681–6. https://doi.org/10.1515/cclm-2020-0022.Search in Google Scholar PubMed

21. Eichler, I, Eichler, HG, Rotter, M, Kyrle, PA, Gasic, S, Korn, A. Plasma concentrations of free and sulfoconjugated dopamine, epinephrine, and norepinephrine in healthy infants and children. Klin Wochenschr 1989;67:672–5. https://doi.org/10.1007/bf01718028.Search in Google Scholar

22. Sastry, S, March, C, Garibaldi, L, McPhaul, M, Wheeler, S, editors. The effect of phlebotomy and placement of an intravenous catheter on plasma catecholamine and serum copeptin concentrations. Hormone research in paediatrics. Allschwilerstrasse 10, Ch-4009 Basel, Switzerland: Karger; 2022.Search in Google Scholar

23. Aykanat Girgin, B, Gol, I. Reducing pain and fear in children during venipuncture: a randomized controlled study. Pain Manag Nurs 2020;21:276–82. https://doi.org/10.1016/j.pmn.2019.07.006.Search in Google Scholar PubMed

24. Siegenthaler, J, Walti, C, Urwyler, SA, Schuetz, P, Christ-Crain, M. Copeptin concentrations during psychological stress: the PsyCo study. Eur J Endocrinol 2014;171:737–42. https://doi.org/10.1530/eje-14-0405.Search in Google Scholar PubMed

25. Urwyler, SA, Schuetz, P, Sailer, C, Christ-Crain, M. Copeptin as a stress marker prior and after a written examination--the CoEXAM study. Stress 2015;18:134–7. https://doi.org/10.3109/10253890.2014.993966.Search in Google Scholar PubMed

26. Fenske, W, Refardt, J, Chifu, I, Schnyder, I, Winzeler, B, Drummond, J, et al.. A copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med 2018;379:428–39. https://doi.org/10.1056/nejmoa1803760.Search in Google Scholar

27. Tuli, G, Munarin, J, Tessaris, D, Einaudi, S, Matarazzo, P, de Sanctis, L. Distribution of plasma copeptin levels and influence of obesity in children and adolescents. Eur J Pediatr 2021;180:119–26. https://doi.org/10.1007/s00431-020-03777-3.Search in Google Scholar PubMed PubMed Central

28. Timper, K, Fenske, W, Kuhn, F, Frech, N, Arici, B, Rutishauser, J, et al.. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria–polydipsia syndrome: a prospective multicenter study. J Clin Endocrinol Metab 2015;100:2268–74. https://doi.org/10.1210/jc.2014-4507.Search in Google Scholar PubMed

Received: 2023-08-23
Accepted: 2023-11-08
Published Online: 2023-11-23
Published in Print: 2024-01-29

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Mini Review
  3. Outcomes and experiences of adults with congenital hypogonadism can inform improvements in the management of delayed puberty
  4. Original Articles
  5. Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy
  6. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study
  7. MicroRNA-29a and microRNA-122 expressions and other inflammatory markers among obese children with diabetes
  8. Health related quality of life is associated with gastroesophageal reflux symptoms in overweight children
  9. Experience with carnitine palmitoyltransferase II deficiency: diagnostic challenges in the myopathic form
  10. Gender-related differences in cardiometabolic risk factors and oxidative stress among prepubertal children with obesity
  11. Recurrence and survival for patients with thyroid carcinoma in the pediatric age group in the Emirate of Abu Dhabi: retrospective analysis of a multicentre cohort
  12. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty
  13. Ambulatory blood pressure monitorisation in children with recombinant growth hormone treatment
  14. Letrozole combined with rhGH treatment increases the adult height of short pubertal boys
  15. Case Reports
  16. Hypothalamic-pituitary dysfunction in Sturge–Weber syndrome: case report and review of the literature
  17. Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal STX16 deletion
Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2023-0390/html
Scroll to top button